Glucotrack (GCTK) Depreciation & Amortization (CF) (2010 - 2025)
Glucotrack's (GCTK) quarterly Depreciation & Amortization (CF) came in at $9000.0 in Q3 2025, down 10.0% YoY from $10000.0 in Q3 2024, and down 18.18% on a QoQ basis from $11000.0 in Q2 2025.
Glucotrack (GCTK) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Glucotrack (GCTK) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $9000.0 in Q3 2025.
- Quarterly Depreciation & Amortization (CF) fell 10.0% year-over-year to $9000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $28000.0 (down 22.22% YoY) and the FY2025 annual result came in at $42000.0, up 16.67% from the prior year.
- Depreciation & Amortization (CF) slipped to $9000.0 in Q3 2025, from $11000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $14000.0 in Q3 2023 to a low of -$8000.0 in Q4 2023.
- A 5-year average of $7473.7 and a median of $9000.0 in 2021 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) sank 300.0% — and 2024, when it surged 275.0%.
- Tracing GCTK's Depreciation & Amortization (CF) over 5 years: stood at $9000.0 in 2021, then slumped by 55.56% to $4000.0 in 2022, then slumped by 300.0% to -$8000.0 in 2023, then surged by 275.0% to $14000.0 in 2024, then tumbled by 35.71% to $9000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $9000.0 (Q3 2025), $11000.0 (Q2 2025), and $8000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | -8,000.00 |
| Dec 31, 2023 | -8,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |